Medica 2011 catalogue

Israel Medical Innovation

2011

Come meet us at hall 16: G40 in

Israel Medical Innovation 2011

Page Contents

3 Table of Contents (By Category)

7 Table of Contents (By Alphabetical Order)

12 Company Profiles

44 Schedule a Meeting

2

2011
Table of Contents (by category) Click on Company’s name for more details

Category Company

Aesthetics and Dermatology Cnoga
CoolSense Medical
Erika Carmel Ltd.
TavTech

Cardiovascular and Peripheral Vascular BSP Biological Signal Processing
Cnoga
Elitar Medical
HypnoCore
Itamar Medical
Sion Biotext Medical

Diagnostics 3QBD
BSP Biological Signal Processing
Cnoga
DYN Diagnostics
Elitar Medical
HypnoCore
Itamar Medical
Medoc
Vasa Applied Technologies

Disposables and Implantable Albaad
Etview
First Care Products
Intromedix
Mizra Medical
Nava Group
Noam Urim Enterprises
OHK Medical Devices

E.M.S. Beth-El Industries
Etview
First Care Products
Flight Medical

Schedule a Meeting at

Return to Table of Content 3

2011

Category Company

General Health Aerotel
Albaad
Cnoga
CoolSense Medical
EarlySense
Elitar Medical
Itamar Medical
Mizra Medical
Motorika
Nava Group

General Surgery Beth-El Industries
Etview
Intromedix
OHK Medical Devices

Infection Control and Infectious Diseases Albaad
Beth-El Industries
Hyginex
Mizra Medical
NanoVibronix

Industrial OEM Albaad

Intensive Care Etview
Flight Medical

Laboratory Equipment DYN Diagnostics



2011

Category Company

Medical and Hospital Equipment Aerotel
Beth-El Industries
CoolSense Medical
Discover Medical Devices
EarlySense
Erika Carmel Ltd.
ETView
Flight Medical
Hyginex
Intromedix
Motorika
NanoVibronix
OHK Medical Devices
Polytex Technologies
TavTech

Monitoring Cnoga
EarlySense
Elitar Medical
Hyginex
HypnoCore

Neurology and Degenerative Diseases CoolSense Medical
Itamar Medical
Medoc
Motorika

Rehabilitation Erika Carmel Ltd.
Flight Medical
Motorika

Respiratory and Pulmonary Discover Medical Devices
ETView
Flight Medical
HypnoCore
Itamar Medical

Robotics DYN Diagnostics
Motorika

Schedule a Meeting at Services 2P2D Solutions
Arazy Group


2011

Category Company

Telemedicine and Healthcare IT 2P2D Solutions
Elitar Medical
HypnoCore

Urology Mizra Medical
NanoVibronix

Wound and Pain Management Erika Carmel Ltd.
Medoc
NanoVibronix



2011
Table of Contents (by alphabetical order)

Page Company Category

2P2D SOLUTIONS Telemedicine and Helathcare IT
12
Services

13 3QBD Diagnostics

General Health
14 Aerotel
Medical and Hospital Equipment

Albaad Disposables and Implantable

General Health
15 Industrial OEM
Infection Control and Infectious Diseases

16 Arazy Group Services

Beth-El Industries Medical and Hospital Equipment
17 E.M.S
General Surgery

BSP Biological Signal Processing Diagnostics
18
Cardiovascular and Peripheral Vascular

Cnoga Monitoring
19
Diagnostics

General Health
Aesthetics and Dermatology



2011

Page Company Category Therapeutic
Area(s)

CoolSense Medical Medical and Hospital Equipment
20
General Health
Neurology and Degenerative Diseases

Discover Medical Devices Medical and Hospital Equipment
21
Respiratory and Pulmonary

DYN Diagnostics Diagnostics
22 Robotics
Laboratory Equipment

EarlySense Medical and Hospital Equipment
Monitoring
23
General Health

Elitar Medical Diagnostics
24 Monitoring
Telemedicine and Healthcare IT
General Health

Erika Carmel Ltd. Wound and Pain Management
25
Rehabilitation

Disposables and Implantable
ETView
26 Intensive Care
General Surgery
E.M.S



2011

Area(s)

First Care Products Disposables and Implantable
27
E.M.S

Flight Medical Medical and Hospital Equipment
28
Rehabilitation
Intensive Care
E.M.S

Hyginex Monitoring
29

HypnoCore Diagnostics
30 Medical and Hospital Equipment
Monitoring
Telemedicine and Helathcare IT

Intromedix Disposables and Implantable
31 Medical and Hospital Equipment
General Surgery

Itamar Medical Diagnostics
32 Cardiovascular and Peripheral Vascular
General Health



2011

Area(s)

Medoc Diagnostics
33 Neurology and Degenerative Diseases
Wound and Pain Management

Mizra Medical Disposables and Implantable
Urology
34
General Health

Motorika Medical Medical and Hospital Equipment
Robotics
35 Rehabilitation
General Health

NanoVibronix Urology
36

Nava Group Disposables and Implantable
37
General Health

Noam Urim Enterprises Disposables and Implantable
38 Industrial OEM
General Health

OHK Medical Devices Medical and Hospital Equipment
39
General Surgery
Disposables and Implantable



2011

Area(s)

40
Polytex Technologies Medical and Hospital Equipment

41
Sion Biotex Medical Disposables and Implantable

42
TavTech Medical and Hospital Equipment

43
Vasa Applied Technologies Disposables and Implantable
Monitoring
Diagnostic
Urology
Intensive Care



2011

2P2D SOLUTIONS www.2p2d.com

Category: Company at a Glance
2P2D Solutions Ltd. is a pioneering technology-based company developing unique
Telemedicine and solutions for various unmet needs within the healthcare, biotech and pharmaceutical
Healthcare IT industries.
2P2D Solutions Ltd. has developed a breakthrough automated drug monitoring system for
Services use in clinical drug trials that incorporates a portable, personalized medication dispensing
device using proprietary 2P2D technology.

Technology and Product(s)
Company Status: 2P2D Solutions Ltd. has developed ClinicAid, a breakthrough automated drug monitoring
Complete Validation system that incorporates a portable medication dispensing device using proprietary
Study 2P2D technology. The system dispenses personalized drug dosages designated for each
specific patient or group of patients. After patient identification has been fully authorized,
according to the designated clinical trial treatment regimen. This exclusive medication
management system, for use in clinical drug trials, ensures unequaled compliance,
accountability and accuracy.

The Company’s telemedicine solution provides:
• Complete and real-time knowledge of the participant’s compliance and adherence to
the trial protocols.
• Reduced overall duration of the clinical trial period.
• Increased participant’s compliance and adherence to the given medication.
• Cost effective solution for clinical trial packaging and drug accountability.

Goal
Objectives: Investment, Strategic Alliances
Target businesses: CROs, Pharma companies, Hospitals
Target Countries: Worldwide



2011

3QBD www.3qbd.com

Located in Arad, Israel, 3QBD Ltd. is an ISO certified start up medical device company.
Diagnostics The company has developed the VGTest, is an In-Vitro Molecular Diagnostic (IVD) device
based on Ion Mobility Spectrometry (IMS) which is used currently for detection of Vaginal
Discharge Infections (VDI).
In December 2009 3QBD Ltd. received the European CE mark for the VGTest, a device
capable of detecting and provides a positive/negative indication for Bacterial Vaginosis
(BV), the most prevalent women’s vaginal infection within 60 seconds.
Future development plans for 3QBD include further research into the VDI field, to detect
additional infections and expanding to other diseases like STD and Cancer, to offer rapid,
accurate results. Further expending to other markets like food and livestock.

IMS (Ion Mobility Spectrometry) Technology
3QBD’s technology is based on the well established and scientifically proven Ion Mobility
Spectrometry (IMS) technology – first used successfully to detect drugs and explosives.
Today IMS is being used to detect presence and type of infection.
Chemical changes in living systems, or degradation of cells after death through
enzymatic and microbial processes, are accompanied by the breakdown of amino-acids
and production of biogenic amines. Pathological conditions in the human body may be
expressed in the formation of biogenic amines, so that elevated levels of biogenic amines
may be indicative of dysfunctions. IMS is a sensitive instrumental technique for detecting
volatile compounds. It is based on measuring the velocity of ions (ion mobility) drifting
through a gas bath under the influence of an electric field.
The Product
The device works by measuring biogenic amines that are present at elevated levels in
infections and diseases and provides a rapid and accurate indication. In the case of the
BV the result is provided within one minute. The VGTest for BV spares the physician from
having to perform the Amsel Test and “whiff tests” of vaginal fluid or spend time waiting
for laboratory Gram Stain results

Goal
Objectives: Distribution for BV, Strategic allaincess, R&D Funding
Target businesses: Women’s Health professionals, gynecologists, obstetricians, hospitals
and health clinics



2011

Aerotel www.aerotel.co.il

Aerotel is one of Israel’s longest established high tech companies, specializing in the
manufacturing of communication and medical devices. Aerotel is known for being the
General Health
first company in Israel to develop an interactive voice response (IVR) system as well as the
portable “Hi-Pack” ECG gauge. The company has exported its products internationally to
Medical and
approximately 40 countries. Its large and diverse customer base includes leading multi-
Hospital Equipment national corporations such as AT&T.
The innovative MDwave system is a revolutionary development in the frequency therapy
field which brings new hope to patients who have been unable to treat themselves by
Company Status: means of conventional medicine.
Clinical Trials Based on extensive experience in offering individualized personal service to patients,
Aerotel has designed the MDwave to provide maximum flexibility and efficiency to meet
each patient’s distinctive requirements. Aerotel experts are continually working to include
the latest Frequency Medicine knowhow, in the MDwave system. This product has been
developed over an eight-year period and is complaint with the following standards: FCC
and CE 60601-1 and 2.

Aerotel Ltd. has developed a breakthrough medical device, known as MDwave, which
restores energy levels and treats chronic and acute conditions through the use of
Frequency Medicine. Recent studies have demonstrated the positive effect of a low
strength electromagnetic field in specific frequencies, on various systems of our body,
demonstrating high efficacy of such treatments.
MDwave is based on creating a low electromagnetic field that impacts the human cell
properties under health and diseased conditions. This field delivers a safe electromagnetic
energy to the human cells, which encourages them to return to proper and balanced
function, and to operate in a healthy and harmonious way. This enables the immune
system to improve its ability to withstand the daily battle against energy-sapping pollutants,
hence increasing the body’s ability to heal itself.
MDwave is a completely safe, compact and easy-to-use device for administering Frequency
Medicine therapy, via an Electromagnetic field. To get started, you simply connect the MDwave
to a computer and choose from an extensive list of treatments the desired routine for your
patient. Once the treatment routine is set, the MDwave operates without a computer.

Goal
Objectives: Searching for distributors
Target businesses: Distributors



2011

Albaad www.albaad.com

Albaad is one of the three leading producers of wipes worldwide. As a fully integrated
Disposables and converter with production facilities in Germany, US and Israel, global R&D, regulatory
suport and engineering teams, Albaad is a preferred contract manufacturing partner for
Implantable
renowned multinationals and retailers.
General Health We don’t just make wet wipes; we make it our business to know everything there is to
know about them, constantly studying customer needs, market trends and technological
Industrial OEM innovations.

Infection Control
and Infectious
Albaad has registered a range of products intended for professional and consumer
Diseases
healthcare use. Our disinfection products are registered as medical device class 2a (FDA
and EPA where applicable). Production is also ISO 13485 certified.
Company Status: The range includes several surface and medical device disinfectants, hand hygiene, patient
care and bathing kits, adult incontinence wipes and several consumer solutions including
Initial Revenues
natural fever relief, jellyfish relief, hemorrhoids relief and antiseptic wipes.
Albaad wipes are one-step ready for use wipes, tailored to meet our customers’ special
needs and requirements. They are made with soft fabrics and impregnated with gentle
yet effective liquids. The wipes are produced and tested according to stringent standards
and inspected by strict quality assurance procedures.

Goal
Objectives: Seeking disinfection liquid customers who wish to find a wipe expert partner
to expand their line with wipes in Europe.
Seeking Private Label manufacturing opportunities for Healthcare distributors in the EU
and worldwide.
Target businesses: Institutional distributors, disinfection brands and consumer healthcare
brands
Target Countries: EU, worldwide



2011

Arazy Group www.arazygroup.com

The Arazy Group expertise is regulatory affairs and quality assurance for the medical
Services device industry.
Arazy Group offers medical device registration services in more than 53 countries and have
gained market clearance for medical devices and IVDs in North and South America, most
Company Status: European countries, various Asian markets, MENA, Africa and Australia. We implement
advance global regulatory products that enable our client to overcome the traditional;
Revenue Growth
multiple-country regulatory compliance that is currently achieved through multiple-
submission processes.
For more than 16 years, our professional consultants have utilized validation, verification
and regulation processes on a diverse portfolio of medical devices,and are responsible for
thousands of successful registrations globally. Our customized solutions accommodate all
stages of medical device’s life cycle and our adaptable services fit any application and any
size organization. We Expedite Success of Safe Medical Devices.

GlobaR™ – One World Process™
Traditionally, multiple-country regulatory compliance is achieved through multiple-
submission processes. The common practice is fragmented, inefficient, costly and time
consuming.
GlobaR™ regulatory intelligence system generates unique Global Master Regulatory File
for any medical device called a GlobaR™ dossier. The following registration process is
quick and efficient since this single file complies with international harmonized standards,
local standards and manufacturing quality management system, creating one universal
dossier which shows your device is safe and effective.
Whether you are seeking enter your device into one market or multiple markets, we have
the solution Our experts are often outsourced for quality and regulatory (QA/RA) positions
to design and implement regulatory strategy for some of the most advanced and complex
devices. Our past experiences comprise of successful registrations of various medical
device categories such as, Drug Delivery, Imaging and Navigation systems, Diagnostic
Software Energy emitting technology, Therapeutic Devices, Combination Devices, Active
and Passive Implants, Diabetic Products, IVDs, Surgical Disposables, Dental Implants and
Dental Lab Products.

Goal
Objectives: Increase client base and locating local agent in additional countries.
Target businesses: Medical device manufactureres, regulatory affairs consultants and
R&D companies



2011

Beth-El Industries www.beind.com

Beth-El Industries is a leading developer and manufacturer of medical negative pressure
isolation systems and collective NBC filtration systems.
Medical and Drawing on more than 30 years of experience in the air filtration field, Beth El Industries
Hospital Equipment Ltd. now offers the medical market an array of stationary and portable Isolation Chambers,
Clean Rooms and stand-alone Air Filtration Systems for applications in hospitals and
Infection Control ground or airborne ambulances.
and Infectious Beth-El’s IsoArk® isolation chambers are designed to quarantine infected people and
protect the outside enviroment from contagious diseases like SARS, Ebola and TB.
Diseases
A unique series of products was developed and are now used by International Disaster
Relief organization in difficult environments worldwide.
E.M.S
Our main features:
General Surgery • Quick and effective isolation • Simple and fast assembly with no additional tools
• Portable solution can be brought to the problem • Variety of sizes and custom
manufacturing according to our client’s requests • Costs only a fraction of the price of a
Company Status: permanent stationary isolation rooms.
Beth-El Zikhron Yaaqov Industries Ltd. is certified for ISO 9001:2000, AQAP-2110 and AS
Revenue Growth
9100 quality management systems and is audited regularly by external entities.

IsoArk - portable, negative pressure chamber designed for a rapid set up of a biologically isolated
environment, for a quick and effective isolation of contagious people and equipment.
The system includes an airlock attached to the main chamber, an air filtration system and
special features that enable to treat the patient from the outside, avoiding contamination
of equipment and staff.
All components of the system meet and exceed today’s standards for infection isolation.
IsoArk N36-4 - portable isolation chamber for transport of a single person in biological
isolation.
Designed specifically for the unique requirements and confided spaces of ambulances
and helicopters, this new product incorporates both Isolation Chamber and Clean Room
features, cleaning both the incoming and the outgoing air. Either positive or negative air
pressure can be created inside the chamber, according to the users needs.
With the battery fully charged, the system can operate for up to 10 hours independently
of external power source and guaranties a complete isolation of the space inside the
chamber during transport.
The “collapsible”, lightweight structure allows for a quick set up of the system and
minimal storage requirements when not in use.

Goal
Objectives:
• Agent able to promote our products in the medical and emergency prepardness sectors
in his country • Contact with potential end customers.
Target businesses: Government agencies in charge of emergency prepardness, hospitals,
importers and distributors of medical equipment, ministry of health, ambulance and
Schedule a Meeting at ambulance equipment companies, airports.


2011

BSP Biological Signal Processing www.bspmedical.com

Founded in 2000, BSP Biological Signal Processing Ltd. is a medical device company with
Diagnostics corporate offices in Tel Aviv, Israel and a US subsidiary – BSP Inc. in Boston, MA. BSP is
publicly traded on the Tel Aviv Stock Exchange since 2006 (TASE:BSP).
Cardiovascular and BSP develops and commercializes a new generation of systems for non invasive diagnosis
Peripheral Vascular and monitoring of Coronary Artery Disease (CAD), based on advanced signal processing of
the ECG signal which integrates the Company’s unique, patented, HyperQ technology.

Company Status:
Initial Revenues BSP has pioneered the clinical implementation of high-frequency ECG and has developed
it into a fast, accurate, low-cost, simple to operate and non-radiating technology for
detecting CAD with greater clinical value than the current standard ECG. The company’s
proprietary HyperQ™ technology extracts and analyses the high-frequency components
of the ECG and provides a unique diagnostic index. Thousands of patients have been
tested with the HyperQ system to date, demonstrating consistently that HyperQ is far
superior to conventional ECG both in sensitivity and specificity, with the potential to
save up to 50% of the unnecessary radioactive imaging procedures, while improving the
standard of care. BSP’s Intellectual Property portfolio is backed by four granted patents
and 14 filed applications in different stages.
HyperQ EX-300: The world’s first advanced system incorporating conventional stress ECG
and the revolutionary highly accurate HyperQ CAD diagnosis in a single, small footprint
unit. This system is FDA (510k) cleared and CE marked.
HyperQ AD-100: Seamlessly integrating the highly accurate HyperQ CAD diagnosis into
the existing workflow, HyperQ AD-100 is an “add-on” to standard stress ECG systems,
enhancing conventional ECG results. This system is FDA (510k) cleared and CE marked.

Goal
Objectives: The Company’s primary strategic objectives include establishing HyperQ as
the first line modality for monitoring and diagnosis of CAD in cardiology clinics, ambulatory
and hospital settings and attaining reimbursement code and premium coverage over
competitors for the HyperQ diagnostic modality in the US. Growth in market penetration
and market share will be achieved through a combination of business partnerships
with equipment and healthcare service providers, and by the establishment of a global
marketing and sales presence.
Target businesses: Distributors specializing in cardiovascular diagnostic devices, leading
manufacturers in the field of cardiovascular diagnostic devices for potential business
partnerships, leading health service providers.



2011

Cnoga Medical www.cnoga.com

Cnoga Medical is an innovative developer of easy-to-use, touch free and non-invasive
medical devices.
Monitoring
It is Cnoga’s belief that the time is soon approaching when most blood tests will be
Cardiovascular and conducted by the patients themselves, in the comfort of their own homes, and with a
Peripheral Vascular simple non-invasive device.

Diagnostics
General Health CNOGA Medical’s technology provides a new patent pending and state of the art solution
for the non-invasive / touch free methods of measuring physiological parameters.
Aesthetics and
Dermatology CNOGA’s technology is based on real-time tissue photography, tissue image color is being
processed in real-time, providing the temporarily color distribution, using dynamic range
of at least 36 color-depth representing over 6.8^10 color combination then by using
Company Status: sophisticated mathematical algorithm, the vast amount of information is being computed
Initial Revenues and analyzed for detecting the correlation between temporarily color pigmentation and a
specific bio or physiological parameter.
Products:
The TensorTip VSM – Pulse rate, Blood Pressure and SpO2 monitoring device
The Hemoximeter – Hemoglobin, Pulse rate, SpO2 monitoring device
The Glucometer – Blood glucose, non-invasive, monitoring device

Goal
Objectives: Meet potential business partners and distributors as well as potential
customers
Target businesses: Medical Device Distributors, hospitals and medical insurance
companies
Target Countries: Global



2011

CoolSense Medical www.coolsense.net

COOLSENSE Medical Ltd. is a subsidiary of the M.D. Clinic Group based in Tel-Aviv, Israel;
an established and prestigious medical health center whose specialty in non-surgical
Medical and
aesthetic procedures serve an extensive network of cosmetic treatment clinics.
Hospital Equipment
CoolSense Medical Ltd. was responsible for the R&D that preceded the manufacture of
Aesthetics and the innovative hand-held CoolSense™ pain numbing applicator. CoolSense’s successfully
Dermatology implemented concept offers medical personnel, aestheticians and the general public a
revolutionary but simply operated instrument that eliminates the pain and discomfort of
General Health injection procedures. CoolSense™ Pain Numbing Applicator which received CE approval,
FDA Certification as well as the Israeli “Certificate of Free Sale” is in use worldwide.
Neurology and CoolSense Medical intends launching MIGROCALM™ during Medica 2011. MIGROCALM™
Degenerative is an innovative self-regulated therapeutic device for the emergency relief of severe
Diseases migraine type head pain.

Company Status: Technology and Product(s)
The innovative CoolSense™ device, when applied to the skin immediately anesthetizes the
Initial Revenues
site of injection with no after effects. The CoolSense Pain-Free Injection Applicator has
been accepted as an indispensable instrument for health care personnel when performing
medical or cosmetic skin invasive procedures. The CoolSense™ Applicator is also an
invaluable tool that greatly improves the quality of life for individuals who are obliged to
undergo injection procedures on a daily basis.
CoolSense™ acts within 3-5 seconds to do away with the stress and fear that is associated
with receiving injections, the most common health-care procedure worldwide.
The MIGROCALM™ - An innovative self-regulated therapeutic device for the emergency
relief of severe migraine type head pain. MIGROCALM™ has been designed for personal
use in the home; offers drug-free, noninvasive and highly effective relief of severe migraine
associated head pain.

Goal
Objectives: Finding potential distributors for main European and Latin American countries
Target Countries: Germany, France, Switzerland, UK, Latin America.



2011

Discover Medical Devices www.discovermedical.com

Discover Medical Devices (DMD) has developed a revolutionary new Continuous Positive Air
Medical and Pressure (CPAP) interface – the SomnuSeal masks line for Obstructive Sleep Apnea (OSA).
Hospital Equipment Patients quickly adjust to the comfortable self-adaptable oral mask, solving the market’s
greatest problem – how to increase the low compliance rates for CPAP treatments. This is
Respiratory and an unmet need and DMD is the first to successfully address it. DMD makes it possible for
Pulmonary the market, with its well established distribution, sales and reimbursement infrastructure,
to grow from $3B and reach its full $30B potential.
SomnuSeal benefit for a strategic partner:
Company Status:
• Will increase worldwide market by >3b$/yr
Clinical Trials • Answers an unmet need (no current competition)
• Perceived “Innovative” and “Leading edge” technology.
• Will provide a massive competitive advantage and ‘locking in’ of the newly acquired

market share of non compliant patients

Approximately 5% of the population requires CPAP treatment for OSA, including more
than 15 million people in the US and 350 million more around the world.
DMD designed the revolutionary SomnuSeal masks from the ground up to solve the most
serious problem in the OSA market today – despite the dangers of OSA, roughly 50%
of diagnosed patients stop their CPAP treatment because they cannot sleep comfortably
with the cumbersome masks that exist today.
In contrast to available traditional masks, DMD’s solution (the SomnuSeal masks line) uses
the natural oral cavity anatomy to create the seal required for effective CPAP treatment.
This innovative development makes it very easy for patients to quickly adjust to the DMD
small self-adaptable mask, which does not occupy external facial structures, does not
contact sensitive internal oral structures, and does not create any of the side effects that
are typical of existing devices.
The SomnuSeal is the first and only mask that addresses the non compliant patient market
segment successfully.

Goal
Objectives: To establish distribution network
Target businesses: Distributors that are experienced and successful in sales to sleep
apnea patients



2011

DYN Diagnostics www.dyn.co.il

Dyn Diagnostics Inc. is engaged in marketing, sales and support scientific and engineering
field tests of body fluids IVD - (In Vitro Diagnostics) and in research laboratories (Applied
Diagnostics
Science).
Robotics Dyn Diagnostics was founded in 1990 and since its inception some twenty years ago, is
the exclusive representative in Israel of Roche Diagnostics, which is the world’s largest and
Laboratory leading company in the IVD field.
Equipment The company completes it’s product line in which Roche is inactive by representing leading
companies such as - (Horiba ABX, Grifols, Aesku.Diagnostics etc.), wide product range
allows the perfect offering and comprehensive solutions in the field of diagnostics.
Company Status: Dyn Diagnostics is working to implement technologies, innovative processes and advanced
Revenue Growth testing of human body fluids in the various performance sites. The company’s activity is
based on a foundation of over a hundred employees with a broad education and skills such
as - biological sciences and engineering, information systems, distribution and logistics as
well as on experience and knowledge accumulated in the last twenty years.

DYN DS Decapper, Sorter and Archiver
The DYN DS is a primary sample decapper/sorter and archiver that is built to efficiencies.
The DYN DS decaps different types of closures on standard primary sample tube sizes
and automatically sorts up to 1,000 tubes per hour. Tubes are sorted for any laboratory
analyzer or target and then finally for archiving.
Genotype DNA marker kits
We at Dyn market commercial vegetable DNA marker tests.
We have been marketing DNA marker test kits, and services locally, for more than 3 years,
to all major local vegetable breedersseed companies.
Our customers use our test either as a DNA marker selection tool to assist breeders, or as
a post control tool to confirm seed production purity.

Goal
Objectives:
• Establish Joint Ventures;
• Find Business Partner that would like to represent our products in various countries;
• Establish business reletaions with international Medical Device companies looking to
enter the Israeli market.



2011

EarlySense www.earlysense.com

EarlySense is bringing to market an innovative contact-free patient supervision
technology.
Medical and
EarlySense’s continuous early sensing capabilities and patient management tools empower
Hospital Equipment
the medical staff in the unmonitored units to improve clinical outcomes and reduce
Monitoring pressure ulcers and patient falls by measuring key parameters through a sensor places
underneath the patient’s mattress.
General Health The continuous patient supervision device that follows and documents patients’ vital signs
and movement, allows nursing staff to proactively reduce adverse events.
EarlySense’s system bridges the critical time gap between patient deterioration and
Company Status: clinician intervention. In light of the Joint Commission’s 2009 Patient Safety Goals for
Initial Revenues healthcare organizations, EarlySense’s technology offers a timely solution for detecting
changes in a patient’s condition, while also assisting nurses to focus on the patients who
need their immediate attention.

EarlySense’s technology has three main components:
1. a unique single plate sensing unit
2. a bedside monitor that processes and displays the measured data; and -
3. a Central Display Station that enables complete coverage of a unit wide set of monitors
at the nurses’ station and the different alerts are delivered to the nurses’ handheld
devices.
The system’s built-in management tools include a wide range of reports on the status of
patients at all times and can be printed for documentation and clinician analysis. Once
placed under a bed mattress, the sensing unit immediately self-activates when sensing
the patient in bed. The system is FDA cleared and CE approved and has been shown to
improve clinical outcomes in general care units.

Goal
Objectives: To be a market leader in the Medical Supervision Field
Target businesses: Sales in USA, Major Clniical study in Harvard/leading university
Target Countries: US, Europe



2011

Elitar Medical www.elitr.com

Elitar Medical is a medical device company founded in Israel in 2005. The company’s
mission is to offer a full range of non-invasive, multi-parameter patient monitoring devices
Diagnostics
and health management software tools to the full satisfaction of its customers and end-
Monitoring users.
Elitar stations can be used for preventive screening for emergency room of national
Telemedicine and hospitals. Elitar develops and manufactures distinct and innovative products hardware
Healthcare IT and software.
The company’s unique approach encourages the adoption of a preventative medicine
Cardiovascular and and healthy lifestyle by simplifying the diagnosis and implementation processes by health
Peripheral Vascular stations, both of the individual and for the accompanying professionals.

General Health
Elitar provides: health station, specially designed to meet the needs of individuals and
Company Status:
organizations that either wish to cut down their costs (e.g., hospitals and retirement
Initial Revenues homes), to increase their profits (e.g., pharmacy chains and gyms), or to improve their
health and nutrition management.
The health station provide gold standard measurement some or all of the following vital
signs: height, weight, BMI (Body Mass Index), RMR (Resting Metabolic Rate),hand grip
strength test, body composition, blood pressure, pulse rate, electrical activity of the heart
(EKG), heart rhythm regularity oxygen saturation, body temperature – all through a quick,
non-invasive, single-posture process. In addition, they can be complemented by external
monitoring devices.
Elitar’s health station is automatically subscribed to the complementary health and weight
management software BioFat and can be subscribed to Telehealth CheckUp, Elitar’s most
advanced health station model, also includes video-conferencing any other external
database, including electronic medical records (EMRs) and other telecommunications
features, and can be also compatible with the medical magnetic or smart card.

Goal
Objectives: To establish distribution network worldwide, joint-ventures with customers
or distributors of diagnostic devices, health insurance companies
Target businesses: Hospitals, private clinics, medical devices distributors, health spa
channels, pharmacies
Target Countries: Europe, Asia, North Africa, Middle East



2011

Erika Carmel Ltd. www.gd-energies.com

As a company whose goal is to bring innovations in treatment, care, and quality of life to
Wound and Pain more and more people, we are proud to present you with cutting edge technology in soft
Laser Therapy: B-Cure Laser is the world’s first portable soft Laser medical device WITH
Management
THE HEALING POWER OF A CLINIC.
Aesthetics and B-CURE Laser is recommended by the best leading specialists and is used widely in Israel
Dermatology by the leading pain clinics, wound healing clinics, and orthopedic departments in the
following hospitals: Hadassah-Jerusalem, Sourasky, Rambam, and Shiba (Tel Hashomer).
Rehabilitation It is also used in physiotherapy clinics of Israeli Defense Forces, leading sports clubs, and
the best sportsmen in Israel, as well as by thousands of individuals for self-treatment at
Medical and home.
Hospital Equipment On January 2010 B-Cure Laser received the European CE 0120 approval for 16 indications
and is presently being exported to some European countries. CE 0120 approved indications
for the B-Cure Laser are: knee pain, neck pain, pain in lower and upper back, sports
Company Status: injuries, muscle pain, arthritis, fibromyalgia, tennis elbow, achilles tendonitis, carpal tunnel
Revenue Growth syndrome, inflammation, wound healing, burns, fresh surgical scars, post-pregnancy
stretch marks, acne, herpes simplex, dental medicine, acupuncture.

B-Cure Laser - LLLT 808 - Low Level Laser Treatment
The soft-laser affects the skin’s surface and simultaneously penetrates the skin without
heating or hurting the skin. Soft laser treatment biostimulates the body’s natural healing
mechanism on a cellular and systemic level. The result: every kind of cell receives the
energy required for activating and enabling optimal functioning in the body, thus allowing
it to “self-heal” and naturally overcome specific problems.
B-CURE LASER - an international breakthrough in soft-laser therapy for professional and
personal treatment of the above mentioned indications.
Thanks to an exclusive, patent-pending development, we have created an exceptional
combination: the power and full coherence of a clinic’s soft-laser device over a large
area of 4.5 cm², with a portable, rechargeable, safe and easy-to-use device – all at a
reasonable price.
The result: a perfect combination of the most effective therapy with the ability to provide
immediate and continuous treatments, thus enabling high quality and fast recovery in
shorter individual treatment times, and with less total healing time.
OUR INNOVATION FOR MEDICA 2011: B-CURE LASER PROFESSIONAL.

Goal
Objectives: Distribution
Target businesses: End-users for self-treatments at home, Pharmacies-a unique business
model, Clinics, Hospitals, Sports teams, Athletes, Security forces, Home care, Nursing
homes.
Schedule a Meeting at Target Countries: EU, USA, South America, Australia


2011

ETView www.etview.com

ETView is a commercial stage, publicly traded medical device company focused on
Disposables and combining airway management with continuous direct visualization for multiple
thoracic surgical procedures as well as long term ventilator dependent patients. ETView
Implantable
manufactures the Tracheoscopic Ventilation Tube (TVT), an endotracheal tube fitted with
Intensive Care a camera and a light source. TVT combines high-flow ventilation, airway management
and continuous video monitoring to overcome current limitations and associated adverse
General Surgery surgical procedure events during lung isolation surgeries as well as managing and limiting
potential surgical injuries resulting from percutaneous tracheotomy and anticipated
Respiratory and difficult intubations.
Pulmonary The TVT is also sold as a trainer, and is the ideal device for teaching and refreshing
intubation skills to medical students, anesthesiology residents and emergency personnel.
E.M.S

Medical and Technology and Product(s)
Hospital Equipment ETView’s patented single-use tracheoscopic ventilation tube (TVT) incorporates a video
camera and light sourc embedded in the tip of an endotracheal tube. The images from
the TVT can be viewed on ETView’s dedicated monitors, or on other hospital medical
Company Status: monitors.
Revenue Growth With a camera at this critical location, medical personnel can effectively monitor surgical
procedures such as the placement of endo-bronchial blockers in lung isolation procedures
and the performance of percutaneous tracheotomy in long term ventilated patients in
the ICU as well as constantly monitor the endotracheal tube tip’s position in such patient
groups.
The TVT is indicated for use in the OR and ICU.

Goal
Objectives: To find distributors which will sell the TVT in their respective markets



2011

First Care Products www.firstcareproducts.com

First Care Products specializes in the development and marketing of new products for pre-
Disposables and hospital emergency medical situations. The company’s mission is to provide intelligent,
innovative, effective and simple to use products which assist in life-saving, improve the
Implantable
treatment provided and yield significant savings in time and resources.
E.M.S Save One Life, Save A World
Active in medical R&D, the company develops beneficial solutions for pre-hospital
medical emergencies. First Care Products provides medics, first responders and the
Company Status: injured themselves with easy and quick to use, effective products for the control of
Revenue Growth hemmorhage resulting from trauma that save lives and greatly boost the treatment
provided whether on the battlefield, homefront or accident scene. The company brings
its years of comprehensive R&D and field experience to create products that when every
second counts make the difference between life and tragedy.

The Emergency Bandage
First Care Products’ first and flagship product, The Emergency Bandage in all its versions
has been designated as the “STANDARD” Personal Field Dressing by numerous major,
quality military organizations and is being utilized by Special Forces and military medical
corps worldwide. The Emergency Bandage is combat and clinically proven, being relied
upon as an integral and vital component in the treatment of hemorrhage and trauma
related injuries.
Beyond Military Use
In addition to militaries around the world, First Care Products supplies its innovative
bandages to governmental and private emergency medical services, Fire Rescue, Police and
Prison Authorities, First-Aid and Survival Academies, and suppliers of first-aid equipment
to the general public.
Worldwide Patent and Approvals
First Care Products’ bandages are Patented worldwide, FDA and CE Approved, with Health
Ministry Approvals in each territory, NATO Reference Numbers, and NSN’s in the USA.
First Care Products manufactures all its products according to the highest International
Standards including ISO 13485.

Goal
Objectives: Strategic Alliances
Target businesses:



2011

Flight Medical Innovations www.flight-medical.com

Flight Medical is a leading manufacturer of high end PORTABLE VENTILATORS. The company
developed and manufacture the legendary HT50 and sold over 15,000 worldwide. Flight
Medical and
Medical has recently launched the Flight 60 ventilator deploying its proprietary leading
Hospital Equipment
edge technology.
Rehabilitation
Intensive Care
The Flight 60 follows the success of more than 15,000 HT50 ventilators deployed
Respiratory and worldwide. Flight 60 is an all-purpose ventilator designed to address the growing need
Pulmonary for ventilation in Home Care, Long Term Care, Emergency, Transport, Hospital and Sub-
Acute. The newly introduced Flight 60 Ventilator is offering a lot more –
E.M.S • A Complete Ventilation Suite
• All Pressure and Volume ventilation modes
• Actual flow measurements (Vti,Vte)
Company Status: • Embedded FiO2 sensor
Revenue Growth • Single limb and dual limb mode
• Autonomous
• 12 hours battery life further extended by hot swap
• Low flow and high pressure oxygen source connection
• Light weight, portable and robust
• Intuitive and Easy to Use
• 7” colored touch screen
• All ventilation parameters on a single screen
• Enhanced graphical display
• Cutting-Edge Dual Micro Piston Technology
• Top clinical performance
• Low power and O2 consumption
• Low heat generation
• Low cost of ownership

Goal
Objectives: Establish global distribution network.
Target businesses: Distributors of medical devices to Home Care, Hospitals and Long
Term Care markets
Target Countries: Asia, Americas, Europe, India



2011

Hyginex www.hyginex.com

Hyginex, founded in 2008, brings a new era to hospital hygiene and infection control.
Hyginex’s technology combines an advanced network of sensors, and an online server to
Monitoring
process and display hand hygiene information.
Infection Control The Hyginex breakthrough enables for the first time real monitoring, management and
and Infectious control of the hospital staff hand hygiene protocol compliance and quality.
With “You Can Control Only What You Can Measure” as its motto Hyginex’s product
Diseases
enables hospital management to receive simple and detailed reports that describe the
Medical and hand hygiene compliance and the washing act.
Hospital Equipment
Company Status: The Hyginex system is a complete wireless hand hygiene monitoring system for healthcare
staff – monitoring whether they clean their hands when needed and if they do so according
Revenue Growth to the protocol.
The system creates detailed reports from the collected data and provides a simple and
flexible user interface for understanding current status and trends of the hand hygiene in
the hospital.
Constant monitoring increases hand-hygiene compliance with almost no management
effort and minimal educational overhead.
On-line Real-time alert system enables management to be updated immediately on any
deviation from the hospital defined hand hygiene policy.
Personal alerting enables workers to receive immediate feedback that enables them to
greatly improve their hand hygiene compliance and quality.

Goal
Objectives: System Marketing, Establishment of Distribution partnerships



2011

HypnoCore www.hypnocore.com

HypnoCore’s vision is to become the global leader of sleep diagnostics services, devices,
and solutions for the medical and consumer markets.
Diagnostics
HypnoCore Ltd. aims to revolutionize the field of sleep diagnostics and improvement
Medical and solutions utilizing web and mobile technologies, medical and consumer devices, to allow
Hospital Equipment accurate and affordable access to sleep diagnostics and health improvement solutions for
the consumer and medical markets.
Monitoring

Telemedicine and Technology and Product(s)
Healthcare IT Following over a decade of academic research and years of R&D, HypnoCore Ltd. has
developed patented, FDA and CE approved technology that analyzes the strongest and
Cardiovascular and most robust signal, the electrocardiogram (ECG), in order to evaluate sleep and diagnose
Peripheral Vascular sleep disorders.

Respiratory and Based on it’s core IP, HypnoCore developed a set of products:
Pulmonary • HC1000P: HypnoCore’s flagship product - reliable, automated diagnostic software that
relies on ECG and oximetry measurements to evaluate sleep and diagnose sleep related
breathing disorders
Company Status: • HC1000: Diagnostic software that analyzes ECG data to diagnose insomnia
Initial Revenues • SleepWay: Web-based system for centralized scoring and data management
• SleepRate: Utilizing the latest sensor technology, internet and mobile technologies,
HypnoCore Ltd. is developing a new lineup of consumer products and services under
the SleepRate brand



2011

Intromedix www.intromedix.com

Category: Company at a glance
Intromedix is an Israeli manufacturer of premium quality, cost- effective, generic, disposable
Disposables and surgical equipment.

Implantable Intromedix has been certified ISO 13485 and has applied a Quality Management System
according to 93/42/EEC. Certification was given by the German Notified Body Medcert.
Medical and
Hospital Equipment
Technology andProduct(s)*
General Surgery • Surgical sutures - absorbable and non absorbable
• Surgical staplers
• Skin staplers
Company status: • Surgical Mesh
Revenue growth *All products are certified

Goal
Objectives: Establish global partnership channels for the distribution of our products
Target countries: All



2011

Itamar Medical www.itamar-medical.com

Itamar Medical Ltd., is a public traded (TASE: ITMR) bio-medical technology company. Itamar
develops and markets noninvasive diagnostic medical equipment based on proprietary
Diagnostics
PAT™ (Peripheral Arterial Tone) Signal. The PAT™ Signal serves as a noninvasive window
Cardiovascular and to the Cardiovascular and Autonomic Nervous Systems.
Peripheral Vascular The PAT Signal is acquired by measuring pulsatile arterial volume changes in the fingertip
by specialized noninvasive probes. Itamar’s FDA cleared and CE marked PAT-based
General Health products are:
• Endo-PAT2000: noninvasive, office-based, user-independent device for endothelial
Neurology and function assessment – the precursor (earliest clinically detectable stage) of cardiovascular
Degenerative disease.
Diseases • Watch-PAT200: ambulatory diagnosis of sleep related breathing disorders and sleep
staging (Wake/REM/Deep sleep/light sleep stages).
Respiratory and Both devices are used in preeminent clinical institutions, research centers and Pharmaceutical
Pulmonary clinical phase studies in over 40 countries which have yielded nearly 300 publications.

Company Status: Technology and Product(s)
Revenue Growth Sleep testing - at home
Considered “best in class”, WatchPAT (FDA cleared and CE marked) is a wrist mounted
device for at-home testing of sleep apneas and sleep staging (REM/Deep Sleep/Light
Sleep/Wake stages). WatchPAT also measures snoring and body position and provides a
perfect combination of natural sleep at home with sleep-lab level data.
WatchPAT works without the multiple cables and electrodes needed by other technologies
which provide in-depth analysis of sleep, so it has an incredibly low failure rate. Yet the
physician gets a comprehensive report with all the clinical parameters needed for patient
treatment and monitoring. While the data is calculated automatically by the WatchPAT’s
software, the physician can easily edit the data too.
Noninvasive cardiovascular risk assessment
Atherosclerosis is the clinical manifestation of endothelial dysfunction. Leading the field
of endothelial function assessment, EndoPAT (FDA cleared and CE marked) is used in
pre-eminent clinical institutions, research centers and Pharma studies. The noninvasive
EndoPAT has been validated by nearly 100 publications and abstracts and provides
clinicians with reliable and reproducible results in an office-based, 15 minute test.

Goal
Objectives: Establish wide distribution network in Europe
Target businesses: Distribution
Target Countries: Brazil, Germany, UK, Spain, France, China, other



2011

Medoc www.medoc-web.com

Medoc is a leading manufacturer of neuro-diagnostic medical systems and advanced
Diagnostics
thermal stimulators for the assessment of chronic pain. Medoc's products evaluate the
Neurology and small and large peripheral sensory nerve fibers (A-delta and C fibers), constituting the
Degenerative "Pain Pathway".
Diseases In 2006, Medoc established the "Medoc Israel" division. This division represents
companies world-wide, promoting and distributing their advanced medical solutions to
Wound and Pain the Israeli market. Medoc Ltd. has developed several strategic collaborations with leading
Management international suppliers from the USA and Europe including Boston Scientific for treating
severe and chronic pain patients by implanting advanced spinal cord stimulation (SCS)
device, Neurotherm for treatment of local pain by applying Radio Frequency (RF) directly
Company Status to the pain source, Epimed for nerve block solutions and catheters and HydroCision for
minimal invasive disc-ectomy.
Revenue Growth

The PATHWAY Pain and Sensory Evaluation System offers new applications for advanced
pain research and fMRI. The PATHWAY model CHEPS (Contact Heat-Evoked Potential
Stimulator) marks a breakthrough in the field of pain-evoked potential, allowing objective
assessment of evoked pain. The PATHWAY model ATS (Advanced Thermal Stimulator)
and PATHWAY model CHEPS are currently used in fMRI studies and in advanced pain
research.
The TSA-II Thermal Sensory Analyzer is used in QST (Quantitative Sensory Testing) to
clinically evaluate small nerve fibers (A-delta and C fibers). The VSA-3000 Vibratory
Sensory Analyzer is used in the assessment of large peripheral nerve fibers (A-beta).
The recently launched Computerized Algometer is a new software-based system, providing
real-time visual and auditory feedback to control and monitor applied pressure rates.
Medoc will launch a series of clinical devices in the coming year to 4 years.
Medoc is also interested in expanding its scope of products in the Israeli market by signing
partnership agreements with promising medical device companies offering breakthrough
technology and innovative products.

Goal
Objectives: Looking for representatives / distributors. Medoc is curretnly in the process
of penetrating the clinical market, and seeking potential collaborations with international
companies which are active in the clinical field. Medoc is also interested in expanding
its scope of products (for the Israeli market only) and in signing exclusive distribution
agreements with promising medical device companies offering breakthrough technology
and innovative products.
Target businesses: Distributors; Medical devices companies offering breakthrough
technologies; Distributing channels for the clinical field.
Target Countries: Optional


2011

Mizra Medical www.mizramedical.com

Mizra Medical Ltd. developed out of a family business, Mizra Latex Products founded by
Disposables and Mr. Zeev Mizra in 1955. The company was incorporated as Mizra Medical Ltd in 2002 and
the company has grown to be the leading producer of latex disposable products in Israel.
Implantable
Mizra carries a complete line of continence care products and distributes specialized
Urology products that provide solutions to the challenges faced by the elderly, disabled, and others
with special needs.
General Health

Infection Control Technology and Product(s)
and Infectious Mizra Medical carries an extensive line of continence care products and distributes
Diseases specialized products that provide solutions to the challenges faced by the elderly, disabled,
and others with special needs.

Company Status:
Goal
Revenue Growth Objectives: Distribution, Alliances
Target businesses: Distributors, Hospitals, Pharmacies
Target Countries: Eastern Europe, USA, Canada, South America



2011

Motorika www.motorika.com

Motorika is a leader in manufacturing robot-assisted solutions to meet the therapeutic needs
of patients suffering from a variety of neurological conditions, including stroke, traumatic
Medical and
brain injury, spinal cord injury, as well as orthopedic and post-surgery dysfunction.
Hospital Equipment
Motorika's products include upper and lower extremities function, providing better
Robotics rehabilitation results through a combination of wide variation and intense repetition.

Rehabilitation
Neurology and ReoGo is the world’s most advanced robotic system for upper limb therapy, designed to
Degenerative facilitate three-dimensional repetitive arm movements through the use of an advanced,
Diseases fully motorized robotic arm. The system is suited for a wide variety of patients in all stages
of stroke recovery.
General Health ReoAmbulator is a high-end robotic gait training device that integrates Body Weight-
Support Treadmill Training (BWSTT) with advanced robotics to help rehabilitate patients
who experience problems with ambulation, balance, coordination, posture or stamina.
Company Status:
Revenue Growth Goal
Objectives: Generate interest from doctors and physiotherapists
Target businesses: Hospitals, rehabilitation clinics



Medica 2011 catalogue

Recomendados

Recomendados

Mais conteúdo relacionado

Semelhante a Medica 2011 catalogue

Semelhante a Medica 2011 catalogue (9)

Mais de trade-gov-il

Mais de trade-gov-il (6)

Último

Último (20)

Medica 2011 catalogue